[1]赵秀娟,钟明松,吴海燕,等.3D打印模具在宫颈癌近距离治疗中重复使用可行性研究[J].陆军军医大学学报(原第三军医大学学报),2022,44(18):1874-1880.
 ZHAO Xiujuan,ZHONG Mingsong,WU Haiyan,et al.Feasibility of repeated using 3D printed applicator in brachytherapy for cervical cancer[J].J Amry Med Univ (J Third Mil Med Univ),2022,44(18):1874-1880.
点击复制

3D打印模具在宫颈癌近距离治疗中重复使用可行性研究(/HTML )
分享到:

陆军军医大学学报(原第三军医大学学报)[ISSN:1000-5404/CN:51-1095/R]

卷:
44卷
期数:
2022年第18期
页码:
1874-1880
栏目:
临床医学
出版日期:
2022-09-30

文章信息/Info

Title:
Feasibility of repeated using 3D printed applicator in brachytherapy for cervical cancer
作者:
赵秀娟钟明松吴海燕陈杜可王冬
重庆大学附属肿瘤医院:妇科肿瘤中心,肿瘤放射治疗中心
Author(s):
ZHAO Xiujuan1 ZHONG Mingsong2 WU Haiyan2 CHEN Duke1 WANG Dong1
1Gynecological Oncology Center, 2Treatment Center of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China
 
关键词:
宫颈癌近距离治疗3D打印模具重复使用
Keywords:
cervical cancer brachytherapy 3D printing applicator repeated using
分类号:
R319; R730.53; R737.33
文献标志码:
A
摘要:
目的通过对比3D打印模具在宫颈癌近距离治疗中预计划与多次实际治疗计划的剂量学,探讨同一模具在同一患者治疗过程中重复使用的可行性。方法收集2019年11月至2020年7月本院收治的接受根治性放疗宫颈鳞癌患者10例,同步放化疗联合3D打印模具辅助近距离治疗。比较3D打印模具预计划与多次实际治疗计划参数:CT扫描次数,高危临床靶区(high risk clinical target area,HR-CTV)体积和D90剂量、靶区适形指数(conformity index,CI),危及器官(organs at risk,OARs)2 cm3接收到的吸收剂量(D2cc);分析患者近期疗效及2年局部控制率(local control rates, LCR)、无病生存率(disease free survival, DFS)、总生存率(overall survival, OS)。两种计划参数对比采用配对样本t检验,患者生存结局采用Kaplan-Meier生存分析。结果共设计3D打印模具10个、完成84次CT扫描、47次实际治疗;预计划与第1次实际治疗HR-CTV体积及CI差异无统计学意义(P>0.05),近距离治疗次数越多,HR-CTV体积越小,且靶区CI越好;HR-CTV D90及OARs均满足临床要求;中位随访23.5个月,2年的LCR、DFS、OS分别为100%、90%、80%。结论3D打印模具可重复用于同一宫颈癌患者近距离治疗,但伴随肿瘤退缩需根据CT定位调整进针深度。
 
Abstract:

ObjectiveTo explore the feasibility of repeated use of the same mold in the brachytherapy of cervical cancer by comparing the dosimetry of the 3D-printed vaginal applicator in the pre-plan and actual treatment plan in the brachytherapy of cervical cancer. MethodsA total of 10 patients with cervical squamous cell carcinoma who received radical radiotherapy in our hospital from November 2019 to July 2020 were reruited in this study. All patients received concurrent radiotherapy and chemotherapy combined with 3D printed applicator assisted brachytherapy. Dosimetric parameters, including CT scan frequency, high risk clinical target area (HR-CTV) volume and D90 dose, conformity index (CI), Dose (D2cc, the absorbed dose received by 2 cm3 of OARs) variation in organs at risk (OARs), and short-term efficacy and 2-year survival outcome of local control rates (LCR), disease free survival (DFS) and overall survival (OS) were compared the parameters of 3D printed mold pre-planning and multiple actual treatment plans. Paired samples t test was used to compare the parameters of pre-planning and actual treatment plans. Kaplan-Meier survival analysis was applied to analyze the survival outcomes of the patients. ResultsTen 3D printing applicators were designed, and a total of 84 CT scans and 47 practical treatments were completed. Only the target volume and CI of the first actual treatment plan were similar to those of the pre-plan, but the difference was not statistically significant (P>0.05). The more times of close treatment, the smaller HR-CTV volume was and the better CI of target area was. Both HR-CTV D90 dose and the OARs dose met clinical requirement. During the median follow-up of 23.5 months,  the 2-year LCR, DFS and OS were 100%, 90% and 80%, respectively.  ConclusionThe 3D-printed vaginal applicator can be used repeatedly for brachytherapy of the same cervical cancer patient, but the needle depth needs to be adjusted by CT positioning.

参考文献/References:

[1]中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6): 474-489. DOI: 10.19401/j.cnki.1007-3639.2021.06.06. 
 
Professional Committee of Gynecologic Tumor of Chinese Anti-Cancer Association. Guidelines for diagnosis and treatment of Cervical Cancer (2021 version) [J]. China Oncol, 2021, 31(6): 474-489. DOI: 10.19401/j.cnki.1007-3639.2021.06.06. 
 
[2]NCCN. Cervical cancer NCCN clinical practice guidelines version in oncology (Version 1.2022) [EB/OL]. [2022-03-20].https: //www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. 
 
[3]CHINO J, ANNUNZIATA C M, BERIWAL S, et al. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline[J]. Pract Radiat Oncol, 2020, 10(4): 220-234. DOI: 10.1016/j.prro.2020.04.002.
 
[4]FOKDAL L, STURDZA A, MAZERON R, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study[J]. Radiother Oncol, 2016, 120(3): 434-440. DOI: 10.1016/j.radonc.2016.03.020.
 
[5]BERIWAL S, DEMANES D J, ERICKSON B, et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer[J]. Brachytherapy, 2012, 11(1): 68-75. DOI: 10.1016/j.brachy.2011.06.008.
 
[6]曾彪, 陈旎, 黄仕雄, 等. 3D打印技术在放疗中的应用进展[J]. 中国医疗设备, 2021, 36(4): 137-140. DOI: 10.3969/j.issn.1674-1633.2021.04.031. 
 
ZENG B, CHEN N, HUANG S X, et al. Application progress of 3D printing technology in radiotherapy[J]. China Med Devices, 2021, 36(4): 137-140. DOI: 10.3969/j.issn.1674-1633.2021.04.031.
 
[7]王俊杰. 3D打印技术在精准粒子植入治疗中的应用[J]. 中华放射医学与防护杂志, 2017, 37(7): 481-484. DOI: 10.3760/cma.j.issn.0254-5098.2017.07.001. 
 
WANG J J. Application of 3D-printing in accurate seed implantation therapy[J]. Chin J Radiol Med Prot, 2017, 37(7): 481-484. DOI: 10.3760/cma.j.issn.0254-5098.2017.07.001.
 
[8]陈媛媛, 袁香坤, 郜蕾, 等. 3D打印模板插植后装放疗联合深部热疗对盆腔复发性宫颈癌的疗效分析[J]. 中国肿瘤临床, 2022, 49(3): 120-123. DOI: 10.12354/j.issn.1000-8179.2022.20211564.
 
CHEN Y Y, YUAN X K, GAO L, et al. Efficacy of three-dimensional-printed template interstitial brachytherapy combined with deep hyperthermia in the treatment of pelvic recurrent cervical cancer[J]. Chin J Clin Oncol, 2022, 49(3): 120-123. DOI: 10.12354/j.issn.1000-8179.2022.20211564.
 
[9]姜玉良, 吉喆, 郭福新, 等. CT引导辅助3D打印个体化非共面模板引导125I粒子治疗头颈部复发/转移肿瘤剂量学研究[J]. 中华放射医学与防护杂志, 2018, 38(11): 842-845, 858. DOI: 10.3760/cma.j.issn.0254-5098.2018.11.008. 
 
JIANG Y L, JI Z, GUO F X, et al. Dosimetry verification of radioactive seed implantation for recurrent malignant tumor of head and neck assisted by 3D printing individual guide plate[J]. Chin J Radiol Med Prot, 2018, 38(11): 842-845, 858. DOI: 10.3760/cma.j.issn.0254-5098.2018.11.008. 
 
[10]中华医学会放射肿瘤治疗分会近距离治疗学组, 中国医师协会放射肿瘤分会妇科肿瘤学组, 中国抗癌协会近距离治疗专委会.宫颈癌图像引导三维近距离后装治疗中国专家共识[J].中华放射肿瘤学杂志, 2020, 29(9): 712-717.DOI: 10.3760/cma.j.cn113030-20200420-00196.
 
Brachytherapy Group of China Society for Radiation Oncology,  Gynecological Oncology Group of Chinese Association for Therapeutic Radiation Oncologists, Brachytherapy Special Committee of Chinese Anti-Cancer Association. Chinese expert consensus on three-dimensional image guided brachytherapy for cervical cancer[J]. Chin J Radiation Oncol, 2020, 29(9): 712-717.DOI: 10.3760/cma.j.cn113030-20200420-00196.
 
[11]MAHANTSHETTY U, POETTER R, BERIWAL S, et al. IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer[J]. Radiother Oncol, 2021, 160: 273-284. DOI: 10.1016/j.radonc.2021.05.010.
 
[12]BALTAS D, KOLOTAS C, GERAMANI K, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy[J]. Int J Radiat Oncol Biol Phys, 1998, 40(2): 515-524. DOI: 10.1016/s0360-3016(97)00732-3.
 
[13]SCHWARZ J K, SIEGEL B A, DEHDASHTI F, et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma[J]. JAMA, 2007, 298(19): 2289-2295. DOI: 10.1001/jama.298.19.2289.
 
[14]HAN K, MILOSEVIC M, FYLES A, et al. Trends in the utilization of brachytherapy in cervical cancer in the United States[J]. Int J Radiat Oncol, 2013, 87(1): 111-119. DOI: 10.1016/j.ijrobp.2013.05.033.
 
[15]MURAKAMI N, KATO T, MIYAMOTO Y, et al. Salvage high-dose-rate interstitial brachytherapy for pelvic recurrent cervical carcinoma after hysterectomy[J]. Anticancer Res, 2016, 36(5): 2413-2421.
 
[16]YOSHIDA K, YAMAZAKI H, KOTSUMA T, et al. Simulation analysis of optimized brachytherapy for uterine cervical cancer: can we select the best brachytherapy modality depending on tumor size? [J]. Brachytherapy, 2016, 15(1): 57-64. DOI: 10.1016/j.brachy.2015.10.002.
 
[17]LINDEGAARD J C, MADSEN M L, TRABERG A, et al. Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer[J]. Radiother Oncol, 2016, 118(1): 173-175. DOI: 10.1016/j.radonc.2015.12.012. 
 
[18]姜玉良, 李宾, 吉喆, 等. 3D打印个体化非共面模板辅助粒子植入时定位与复位误差研究[J]. 中华放射医学与防护杂志, 2016, 36(12): 913-916. DOI: 10.3760/cma.j.issn.0254-5098.2016.12.007.
 
JIANG Y L, LI B, JI Z, et al. Analysis of position errors of 3D printing individual non-coplanar template for radioactive seed implantation for malignant tumor[J]. Chin J Radiol Med Prot, 2016, 36(12): 913-916. DOI: 10.3760/cma.j.issn.0254-5098.2016.12.007.
 
[19]吉喆, 姜玉良, 郭福新, 等. 3D打印个体化非共面模板辅助放射性粒子植入治疗恶性肿瘤的剂量学验证[J]. 中华放射医学与防护杂志, 2016, 36(9): 662-666. DOI: 10.3760/cma.j.issn.0254-5098.2016.09.005.
 
JI Z, JIANG Y L, GUO F X, et al. Dosimetry verification of radioactive seed implantation for malignant tumor assisted by 3D printing individual guide template[J]. Chin J Radiol Med Prot, 2016, 36(9): 662-666. DOI: 10.3760/cma.j.issn.0254-5098.2016.09.005.
 
[20]赵志鹏, 管薇, 赵红福, 等.3D打印模板辅助标准化施源器在ⅢB期宫颈癌影像引导自适应近距离治疗中的应用[J].中华放射肿瘤学杂志, 2020, 29(8): 661-665. DOI: 10.3760/cma.j.cn113030-20200511-00246.
 
ZHAO Z P, GUAN W, ZHAO H F, et al. Application of 3D printing technology-assisted standardized applicator in image-guided adaptive brachytherapy of stage ⅢB cervical cance[J]. Chin J Radiation Oncol, 2020, 29(8): 661-665. DOI: 10.3760/cma.j.cn113030-20200511-00246.
 
[21]张永侠, 袁香坤, 苗珺珺, 等. 3D打印模板应用于局部晚期宫颈癌后装放疗的剂量学研究[J]. 中华放射医学与防护杂志, 2020, 40(7): 519-523. DOI: 10.3760/cma.j.issn.0254-5098.2020.07.005. 
 
ZHANG Y X, YUAN X K, MIAO J J, et al. Dosimetric analysis of 3D-printed minimally invasive-guided template in the brachytherapy treatment of locally advanced cervical cancer[J]. Chin J Radiol Med Prot, 2020, 40(7): 519-523. DOI: 10.3760/cma.j.issn.0254-5098.2020.07.005.
 
[22]王凤玫, 程惠华, 冯静, 等. 3D打印技术引导宫颈癌个体化近距离放疗应用研究[J]. 中华肿瘤防治杂志, 2020, 27(12): 1003-1007. DOI: 10.16073/j.cnki.cjcpt.2020.12.14. 
 
WANG F M, CHENG H H, FENG J, et al. Clinical observation of 3D printing-guided three-dimensional brachytherapy for cervical cancer[J]. Chin J Cancer Prev Treat, 2020, 27(12): 1003-1007. DOI: 10.16073/j.cnki.cjcpt.2020.12.14.
 
[23]赵秀娟, 何亚男, 吴海燕, 等. 3D打印个体化模具在宫颈癌近距离治疗中的应用[J]. 中国肿瘤临床, 2021, 48(8): 400-404. DOI: 10.3969/j.issn.1000-8179.2021.08.693. 
 
ZHAO X J, HE Y N, WU H Y, et al. Application of three-dimensional printed individualized brachytherapy applicators for cervical cancer[J]. Chin J Clin Oncol, 2021, 48(8): 400-404. DOI: 10.3969/j.issn.1000-8179.2021.08.693.
 
[24]SCHERNBERG A, BOCKEL S, ANNEDE P, et al. Tumor shrinkage during chemoradiation in locally advanced cervical cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2018, 102(2): 362-372. DOI: 10.1016/j.ijrobp.2018.06.014.
 
[25]MAZERON R, CASTELNAU-MARCHAND P, DUMAS I, et al. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy[J]. Radiother Oncol, 2015, 114(2): 257-263. DOI: 10.1016/j.radonc.2014.11.045.
 
[26]TANDERUP K, FOKDAL L U, STURDZA A, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer[J]. Radiother Oncol, 2016, 120(3): 441-446. DOI: 10.1016/j.radonc.2016.05.014. 

相似文献/References:

[1]李德志,徐维邦,张哉根,等.高剂量率近距离辐射正常食管的组织学改变与DNA含量变化的研究[J].陆军军医大学学报(原第三军医大学学报),1998,20(02):0.[doi:10.16016/j.1000-5404.1998.02.027 ]
 Li Dezhi,Xu Weibang,Zhang Zaigen.[J].J Amry Med Univ (J Third Mil Med Univ),1998,20(18):0.[doi:10.16016/j.1000-5404.1998.02.027 ]
[2]李德志,李启明,傅尚志,等.外照射加用高剂量率腔内放射治疗食管癌398例临床分析[J].陆军军医大学学报(原第三军医大学学报),1998,20(05):0.[doi:10.16016/j.1000-5404.1998.05.028 ]
 Li Dezhi,Li Qiming,Fu Shangzhi,et al.[J].J Amry Med Univ (J Third Mil Med Univ),1998,20(18):0.[doi:10.16016/j.1000-5404.1998.05.028 ]
[3]李德志,李启明,张青,等.高剂量率腔内治疗与单纯外照射治疗癌性肺不张的疗效比较[J].陆军军医大学学报(原第三军医大学学报),2003,25(10):0.[doi:10.16016/j.1000-5404.2003.10.030 ]
 LI De-zhi,LI Qi-ming,ZHANG Qing,et al.[J].J Amry Med Univ (J Third Mil Med Univ),2003,25(18):0.[doi:10.16016/j.1000-5404.2003.10.030 ]

更新日期/Last Update: 2022-09-23